These include the consensus molecular subtypes (CMSs), the involvement of CRC-driving Hsp90 client proteins, a favorable epichaperome [25], and tumoral Hsp90 overexpression [75,76]. This evidence concerns the gene HSP90AB1 and colorectal carcinoma.